NCT05484765

Brief Summary

Smoking negatively affects the prognosis of periodontal disease by impairing tissue healing. While micronucleus is the most popular parameter for demonstrating DNA damage, inflammatory cell and vascular densities are the most evaluated parameters for determining histopathologic changes in the periodontium. This cross-sectional study aimed to evaluate the effects of heavy cigarette smoking and generalized periodontitis on local genotoxic damage to exfoliated oral epithelial cells as well as histopathologic damage to the periodontium. The investigators hypothesized that the genotoxic and histopathologic damage would be increased in smokers with generalized periodontitis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2019

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2019

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 1, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 2, 2022

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

9 months

First QC Date

July 1, 2022

Last Update Submit

September 26, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Micronuclei counts

    During mitosis, loss of chromatin from chromosomal DNA is manifested by extra-small, abnormal nuclear structures called micronuclei. Of the available cytogenetic analyses, the micronucleus assay is one of the most popular methods for detecting structural and numerical nuclear abnormalities due to its reliability and simplicity. This genotoxic biomonitoring assay makes it possible to provide evidence for the biological assessment of disease susceptibility, diagnosis, and staging in subjects exposed to environmental risk factors.Briefly, smear samples were collected from the attached gingival mucosa of the upper premolar-molar area and the buccal mucosa of the matching cheek using two separate sterile cytobrushes. Samples were fixed on glass slides.

    1 year

  • Histopathologic changes

    Histopathologic damage was evaluated by focusing on inflammatory cell and vascular densities.Biopsy samples were taken from the vestibular area of the maxillary molars during tooth extraction or crown lengthening using a 15C surgical blade and fixed in 10% formalin until analysis.

    1 year

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects were separated into four groups: smokers with generalized periodontitis (SGP; n = 20), non-smokers with generalized periodontitis (NGP; n = 20), smokers with clinically healthy periodontium (SHP; n = 20), and non-smokers with clinically healthy periodontium (NHP; n = 20). The following criteria needed to be met to be considered a periodontitis subject: the presence of generalized periodontitis, the presence of at least 20 teeth, the presence of a molar with an indication of gingivectomy, crown lengthening or extraction with a PD ≥ 5mm, clinical attachment loss ≥ 5 mm, and the presence of at least ten teeth with a PD ≥ 5 mm. The following criteria indicated a clinically healthy periodontium: a healthy and intact periodontium, no PD and BOP.

You may qualify if:

  • Self-reporting as systemically healthy
  • Aged between 18-65 years
  • The presence of at least five teeth in each quadrant
  • To need gingivectomy operations, crown lengthening procedures, or tooth extractions.
  • Smokers had used cigarettes for at least five years with daily consumption of ≥ 20.

You may not qualify if:

  • The presence of a known medical condition that could possibly bias the results
  • Having a medical condition requiring antibiotic prophylaxis for dental treatment
  • The presence of systemic medication taken within the previous six months
  • Excessive alcohol consumption
  • Currently undergoing nicotine replacement therapy
  • Consuming tobacco products other than cigarettes
  • Those with fixed orthodontic appliances
  • History of periodontal therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Begüm Alkan

Istanbul, 34353, Turkey (Türkiye)

Location

Biospecimen

Retention: SAMPLES WITH DNA

smear samples, containing exfoliated oral epithelial cells, were taken from buccal and gingival mucosa

MeSH Terms

Conditions

PeriodontitisSmoking

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesBehavior

Study Officials

  • Begum Alkan

    Private Practice of Periodontology (formerly Istanbul Medipol University)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Periodontology specialist

Study Record Dates

First Submitted

July 1, 2022

First Posted

August 2, 2022

Study Start

November 1, 2018

Primary Completion

July 15, 2019

Study Completion

July 20, 2019

Last Updated

September 28, 2023

Record last verified: 2023-09

Locations